Duchenne Muscular Dystrophy Clinical Trial
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Orthopedic |
| Therapuetic Areas: | Neurology, Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 15 - 20 |
| Updated: | 11/8/2014 |
| Start Date: | June 2013 |
| End Date: | July 2014 |
| Contact: | Donald Rhodes, MD |
| Email: | DrRhodes2@aol.com |
| Phone: | 361-992-9432 |
Double-blind, Randomized, Placebo-controlled Study of VECTTOR Treatment for Duchenne Muscular Dystrophy
The primary objective of this investigation is to assess the effectiveness of transcutaneous
electrical nerve stimulation applied using VECTTOR to reduce the symptoms of Duchenne
Muscular Dystrophy and reduce the impact of DMD upon the participants' quality of life.
The primary outcome measures will include:
1. increased muscle strength and
2. increased range of joint motions.
electrical nerve stimulation applied using VECTTOR to reduce the symptoms of Duchenne
Muscular Dystrophy and reduce the impact of DMD upon the participants' quality of life.
The primary outcome measures will include:
1. increased muscle strength and
2. increased range of joint motions.
Inclusion Criteria:
- Participants must have Duchenne Muscular Dystrophy diagnosis as confirmed by licensed
physician, wheelchair bound, & age 15-20 years old.
Exclusion Criteria:
- Active cancer in the area of application of the treatment, infection, skin infection,
pregnancy, thrombophlebitis, pacemaker, amputation of any part of feet or hands,
taking steroids. In addition, the participant may not be in any other clinical trial
during the time they are in this study.
We found this trial at
1
site
Click here to add this to my saved trials
